These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 31811343)

  • 1. The clinical feasibility of deep learning-based classification of amyloid PET images in visually equivocal cases.
    Son HJ; Oh JS; Oh M; Kim SJ; Lee JH; Roh JH; Kim JS
    Eur J Nucl Med Mol Imaging; 2020 Feb; 47(2):332-341. PubMed ID: 31811343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of PiB visual interpretation with CSF Aβ and longitudinal SUVR in J-ADNI study.
    Okada Y; Kato T; Iwata K; Kimura Y; Nakamura A; Hattori H; Toyama H; Ishii K; Ishii K; Senda M; Ito K; Iwatsubo T;
    Ann Nucl Med; 2020 Feb; 34(2):108-118. PubMed ID: 31749127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Individualized quantification of brain β-amyloid burden: results of a proof of mechanism phase 0 florbetaben PET trial in patients with Alzheimer's disease and healthy controls.
    Barthel H; Luthardt J; Becker G; Patt M; Hammerstein E; Hartwig K; Eggers B; Sattler B; Schildan A; Hesse S; Meyer PM; Wolf H; Zimmermann T; Reischl J; Rohde B; Gertz HJ; Reininger C; Sabri O
    Eur J Nucl Med Mol Imaging; 2011 Sep; 38(9):1702-14. PubMed ID: 21547601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Automated quantification of 18F-flutemetamol PET activity for categorizing scans as negative or positive for brain amyloid: concordance with visual image reads.
    Thurfjell L; Lilja J; Lundqvist R; Buckley C; Smith A; Vandenberghe R; Sherwin P
    J Nucl Med; 2014 Oct; 55(10):1623-8. PubMed ID: 25146124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Automated semi-quantitative amyloid PET analysis technique without MR images for Alzheimer's disease.
    Imabayashi E; Tamamura N; Yamaguchi Y; Kamitaka Y; Sakata M; Ishii K
    Ann Nucl Med; 2022 Oct; 36(10):865-875. PubMed ID: 35821311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive and functional patterns of nondemented subjects with equivocal visual amyloid PET findings.
    Payoux P; Delrieu J; Gallini A; Adel D; Salabert AS; Hitzel A; Cantet C; Tafani M; De Verbizier D; Darcourt J; Fernandez P; Monteil J; Carrié I; Voisin T; Gillette-Guyonnet S; Pontecorvo M; Vellas B; Andrieu S
    Eur J Nucl Med Mol Imaging; 2015 Aug; 42(9):1459-68. PubMed ID: 25952279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visual interpretation of [
    Kim JY; Oh D; Sung K; Choi H; Paeng JC; Cheon GJ; Kang KW; Lee DY; Lee DS
    Eur J Nucl Med Mol Imaging; 2021 Apr; 48(4):1116-1123. PubMed ID: 32990807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AmyloidPETNet: Classification of Amyloid Positivity in Brain PET Imaging Using End-to-End Deep Learning.
    Fan S; Ponisio MR; Xiao P; Ha SM; Chakrabarty S; Lee JJ; Flores S; LaMontagne P; Gordon B; Raji CA; Marcus DS; Nazeri A; Ances BM; Bateman RJ; Morris JC; Benzinger TLS; Sotiras A;
    Radiology; 2024 Jun; 311(3):e231442. PubMed ID: 38860897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of visually equivocal amyloid PET findings from the Alzheimer's Disease Neuroimaging Initiative cohort.
    Oh M; Seo M; Oh SY; Kim H; Choi BW; Oh JS; Kim JS;
    Neuroreport; 2018 May; 29(7):553-558. PubMed ID: 29438267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of visual assessment and semi-quantification for the diagnostic and prognostic use of [
    Mathoux G; Boccalini C; Peretti DE; Arnone A; Ribaldi F; Scheffler M; Frisoni GB; Garibotto V
    Eur J Nucl Med Mol Imaging; 2024 May; 51(6):1639-1650. PubMed ID: 38182839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebral amyloid-β PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study.
    Barthel H; Gertz HJ; Dresel S; Peters O; Bartenstein P; Buerger K; Hiemeyer F; Wittemer-Rump SM; Seibyl J; Reininger C; Sabri O;
    Lancet Neurol; 2011 May; 10(5):424-35. PubMed ID: 21481640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of quantitative assessment of florbetaben PET scans as an adjunct to the visual assessment across 15 software methods.
    Jovalekic A; Roé-Vellvé N; Koglin N; Quintana ML; Nelson A; Diemling M; Lilja J; Gómez-González JP; Doré V; Bourgeat P; Whittington A; Gunn R; Stephens AW; Bullich S
    Eur J Nucl Med Mol Imaging; 2023 Sep; 50(11):3276-3289. PubMed ID: 37300571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fast and Accurate Amyloid Brain PET Quantification Without MRI Using Deep Neural Networks.
    Kang SK; Kim D; Shin SA; Kim YK; Choi H; Lee JS
    J Nucl Med; 2023 Apr; 64(4):659-666. PubMed ID: 36328490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of early-phase [
    Daerr S; Brendel M; Zach C; Mille E; Schilling D; Zacherl MJ; Bürger K; Danek A; Pogarell O; Schildan A; Patt M; Barthel H; Sabri O; Bartenstein P; Rominger A
    Neuroimage Clin; 2017; 14():77-86. PubMed ID: 28138429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Partial-Volume Effect Correction Improves Quantitative Analysis of 18F-Florbetaben β-Amyloid PET Scans.
    Rullmann M; Dukart J; Hoffmann KT; Luthardt J; Tiepolt S; Patt M; Gertz HJ; Schroeter ML; Seibyl J; Schulz-Schaeffer WJ; Sabri O; Barthel H
    J Nucl Med; 2016 Feb; 57(2):198-203. PubMed ID: 26541776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimized classification of
    Bullich S; Seibyl J; Catafau AM; Jovalekic A; Koglin N; Barthel H; Sabri O; De Santi S
    Neuroimage Clin; 2017; 15():325-332. PubMed ID: 28560157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloid-β assessed by florbetapir F 18 PET and 18-month cognitive decline: a multicenter study.
    Doraiswamy PM; Sperling RA; Coleman RE; Johnson KA; Reiman EM; Davis MD; Grundman M; Sabbagh MN; Sadowsky CH; Fleisher AS; Carpenter A; Clark CM; Joshi AD; Mintun MA; Skovronsky DM; Pontecorvo MJ;
    Neurology; 2012 Oct; 79(16):1636-44. PubMed ID: 22786606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Three Automated Approaches for Classification of Amyloid-PET Images.
    Nai YH; Tay YH; Tanaka T; Chen CP; Robins EG; Reilhac A;
    Neuroinformatics; 2022 Oct; 20(4):1065-1075. PubMed ID: 35622223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 4-Year Follow-Up of Subjects with Visually Equivocal Amyloid Positron Emission Tomography Findings from the Alzheimer's Disease Neuroimaging Initiative Cohort.
    Oh M; Seo M; Oh SY; Kim H; Choi BW; Oh JS; Kim JS;
    Nucl Med Mol Imaging; 2021 Apr; 55(2):71-78. PubMed ID: 33968273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of (11)C-PiB equivocal PET findings.
    Hosokawa C; Ishii K; Hyodo T; Sakaguchi K; Usami K; Shimamoto K; Yamazoe Y; Hosono M; Hanada K; Ueda M; Saigo K; Murakami T
    Ann Nucl Med; 2015 Feb; 29(2):164-9. PubMed ID: 25373846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.